Showing results (151-160 of 185) with videos related to
Sort By:
Pageof 19
Arthritis Care & Research|March 26, 2016
Infliximab Versus Conventional Combination Treatment and Seven-Year Work Loss in Early Rheumatoid Arthritis: Results of a Randomized Swedish TrialJonas K Eriksson, Johan K Wallman, Heather Miller, et al.Annals of Surgery|January 26, 2023
Opioid Use After Gastric Bypass, Sleeve Gastrectomy or Intensive Lifestyle InterventionStefan Wallén, Gustaf Bruze, Johan Ottosson, et al.Gastroenterology|October 21, 2018
Increased Mortality of Patients With Childhood-Onset Inflammatory Bowel Diseases, Compared With the General PopulationOla Olén, Johan Askling, Michael C Sachs, et al.Annals of the Rheumatic Diseases|April 17, 2014
Cost-effectiveness of infliximab versus conventional combination treatment in methotrexate-refractory early rheumatoid arthritis: 2-year results of the register-enriched randomised controlled SWEFOT trialJonas K Eriksson, Johan A Karlsson, Johan Bratt, et al.Annals of the Rheumatic Diseases|December 1, 2012
Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in early rheumatoid arthritis: 2-year quality-of-life results of the randomised, controlled, SWEFOT trialJohan A Karlsson, Martin Neovius, Jan-Åke Nilsson, et al.JAMA Surgery|March 29, 2018
Associations of Bariatric Surgery With Changes in Interpersonal Relationship Status: Results From 2 Swedish Cohort StudiesGustaf Bruze, Tobias E Holmin, Markku Peltonen, et al.Inflammatory Bowel Diseases|December 15, 2018
Work Loss Before and After Diagnosis of Crohn's DiseaseÅsa H Everhov, Hamed Khalili, Johan Askling, et al.Journal of Crohn'S & Colitis|August 31, 2018
Sick Leave and Disability Pension in Prevalent Patients With Crohn's DiseaseÅsa H Everhov, Hamed Khalili, Johan Askling, et al.Obesity (Silver Spring, Md.)|June 30, 2017
Change in Use of Sleep Medications After Gastric Bypass Surgery or Intensive Lifestyle Treatment in Adults with ObesityWinda L Ng, Anna Peeters, Ingmar Näslund, et al.Rheumatology (Oxford, England)|September 24, 2010
Detection and evaluation of a drug safety signal concerning pancreatic cancer: lessons from a joint approach of three European biologics registersAnja Strangfeld, Kimme Hyrich, Johan Askling, et al.Pageof 19